Skip to main content

Table 1 Association between mRNA expression of PSF3 and clinicopathological characteristics in 137 patients with colorectal cancer

From: Partner of Sld five 3: a potential prognostic biomarker for colorectal cancer

Variables

Total

PSF3 expression

P-value

Low level

High level

No. of patients

137

66

71

 

Age in years, mean × SD (range)

61.2 × 7.6 (37"86)

59.4 × 7.1 (37"81)

63.5 × 8.8 (42"86)

0.634

Gender, M/F

89/48

42/24

47/24

0.728

Tumor size

   

0.013*

<5 cm

105

55

50

 

≥5 cm

32

11

21

 

Depth of wall invasion

   

0.006*

Tis-T2

81

43

38

 

T3-T4

56

23

33

 

Lymph node metastasis

   

0.047*

Negative

76

39

37

 

Positive

61

27

34

 

Distant metastasis

   

0.125

No

118

58

60

 

Yes

19

8

11

 

TNM stage

   

0.008*

I/II/III/IV

46/54/22/15

28/26/8/4

18/28/14/11

 

Differentiation

   

0.021*

Well/Moderate

94

52

42

 

Poor

43

14

29

 

Adjuvant chemotherapy

   

0.079

Yes

42

22

20

 

No

95

44

51

 

Five-year survival

   

0.002*

Yes

58

35

23

 

No

79

31

48

 
  1. M/F Male/Female, PSF3 partner of Sld five 3, SD standard deviation.
  2. *Significant P-value.